These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 15347712)

  • 1. Quantification of human nicotinic acetylcholine receptors with 123I-5IA SPECT.
    Mamede M; Ishizu K; Ueda M; Mukai T; Iida Y; Fukuyama H; Saga T; Saji H
    J Nucl Med; 2004 Sep; 45(9):1458-70. PubMed ID: 15347712
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of radioiodinated 5-iodo-3-(2(S)-azetidinylmethoxy)pyridine as a ligand for SPECT investigations of brain nicotinic acetylcholine receptors.
    Saji H; Ogawa M; Ueda M; Iida Y; Magata Y; Tominaga A; Kawashima H; Kitamura Y; Nakagawa M; Kiyono Y; Mukai T
    Ann Nucl Med; 2002 May; 16(3):189-200. PubMed ID: 12126044
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 5-[123I]Iodo-A-85380: assessment of pharmacological safety, radiation dosimetry and SPECT imaging of brain nicotinic receptors in healthy human subjects.
    Ueda M; Iida Y; Mukai T; Mamede M; Ishizu K; Ogawa M; Magata Y; Konishi J; Saji H
    Ann Nucl Med; 2004 Jun; 18(4):337-44. PubMed ID: 15359928
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo imaging of human cerebral nicotinic acetylcholine receptors with 2-18F-fluoro-A-85380 and PET.
    Gallezot JD; Bottlaender M; Grégoire MC; Roumenov D; Deverre JR; Coulon C; Ottaviani M; Dollé F; Syrota A; Valette H
    J Nucl Med; 2005 Feb; 46(2):240-7. PubMed ID: 15695782
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantification of nicotinic acetylcholine receptors in human brain using [123I]5-I-A-85380 SPET.
    Fujita M; Ichise M; van Dyck CH; Zoghbi SS; Tamagnan G; Mukhin AG; Bozkurt A; Seneca N; Tipre D; DeNucci CC; Iida H; Vaupel DB; Horti AG; Koren AO; Kimes AS; London ED; Seibyl JP; Baldwin RM; Innis RB
    Eur J Nucl Med Mol Imaging; 2003 Dec; 30(12):1620-9. PubMed ID: 14523584
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Noninvasive evaluation of nicotinic acetylcholine receptor availability in mouse brain using single-photon emission computed tomography with [(123)I]5IA.
    Matsuura Y; Ueda M; Higaki Y; Watanabe K; Habara S; Kamino S; Saji H; Enomoto S
    Nucl Med Biol; 2016 Jun; 43(6):372-8. PubMed ID: 27260778
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 123I-5-IA-85380 SPECT measurement of nicotinic acetylcholine receptors in human brain by the constant infusion paradigm: feasibility and reproducibility.
    Staley JK; van Dyck CH; Weinzimmer D; Brenner E; Baldwin RM; Tamagnan GD; Riccardi P; Mitsis E; Seibyl JP
    J Nucl Med; 2005 Sep; 46(9):1466-72. PubMed ID: 16157529
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Simplified quantification of nicotinic receptors with 2[18F]F-A-85380 PET.
    Mitkovski S; Villemagne VL; Novakovic KE; O'Keefe G; Tochon-Danguy H; Mulligan RS; Dickinson KL; Saunder T; Gregoire MC; Bottlaender M; Dolle F; Rowe CC
    Nucl Med Biol; 2005 Aug; 32(6):585-91. PubMed ID: 16026705
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Imaging of cerebral α4β2* nicotinic acetylcholine receptors with (-)-[(18)F]Flubatine PET: Implementation of bolus plus constant infusion and sensitivity to acetylcholine in human brain.
    Hillmer AT; Esterlis I; Gallezot JD; Bois F; Zheng MQ; Nabulsi N; Lin SF; Papke RL; Huang Y; Sabri O; Carson RE; Cosgrove KP
    Neuroimage; 2016 Nov; 141():71-80. PubMed ID: 27426839
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemical fate of the nicotinic acetylcholinergic radiotracer [123I]5-IA-85380 in baboon brain and plasma.
    Baldwin RM; Zoghbi SS; Staley JK; Brenner E; Al-Tikriti MS; Amici L; Fujita M; Innis RB; Tamagnan G
    Nucl Med Biol; 2006 May; 33(4):549-54. PubMed ID: 16720248
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo relationship between thalamic nicotinic acetylcholine receptor occupancy rates and antiallodynic effects in a rat model of neuropathic pain: persistent agonist binding inhibits the expression of antiallodynic effects.
    Ueda M; Iida Y; Yoneyama T; Kawai T; Ogawa M; Magata Y; Saji H
    Synapse; 2011 Jan; 65(1):77-83. PubMed ID: 20506320
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantification of nicotinic acetylcholine receptors in Parkinson's disease with (123)I-5IA SPECT.
    Oishi N; Hashikawa K; Yoshida H; Ishizu K; Ueda M; Kawashima H; Saji H; Fukuyama H
    J Neurol Sci; 2007 May; 256(1-2):52-60. PubMed ID: 17367812
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 18F-ZW-104: a new radioligand for imaging neuronal nicotinic acetylcholine receptors--in vitro binding properties and PET studies in baboons.
    Valette H; Xiao Y; Peyronneau MA; Damont A; Kozikowski AP; Wei ZL; Kassiou M; Kellar KJ; Dollé F; Bottlaender M
    J Nucl Med; 2009 Aug; 50(8):1349-55. PubMed ID: 19652217
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Validation of an extracerebral reference region approach for the quantification of brain nicotinic acetylcholine receptors in squirrel monkeys with PET and 2-18F-fluoro-A-85380.
    Le Foll B; Chefer SI; Kimes AS; Shumway D; Goldberg SR; Stein EA; Mukhin AG
    J Nucl Med; 2007 Sep; 48(9):1492-500. PubMed ID: 17704243
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 123I-5-IA-85380 SPECT imaging of nicotinic receptors in Alzheimer disease and mild cognitive impairment.
    Mitsis EM; Reech KM; Bois F; Tamagnan GD; Macavoy MG; Seibyl JP; Staley JK; van Dyck CH
    J Nucl Med; 2009 Sep; 50(9):1455-63. PubMed ID: 19690024
    [TBL] [Abstract][Full Text] [Related]  

  • 16. First-in-human PET quantification study of cerebral α4β2* nicotinic acetylcholine receptors using the novel specific radioligand (-)-[(18)F]Flubatine.
    Sabri O; Becker GA; Meyer PM; Hesse S; Wilke S; Graef S; Patt M; Luthardt J; Wagenknecht G; Hoepping A; Smits R; Franke A; Sattler B; Habermann B; Neuhaus P; Fischer S; Tiepolt S; Deuther-Conrad W; Barthel H; Schönknecht P; Brust P
    Neuroimage; 2015 Sep; 118():199-208. PubMed ID: 26037057
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Measurement of alpha4beta2 nicotinic acetylcholine receptors with [123I]5-I-A-85380 SPECT.
    Fujita M; Tamagnan G; Zoghbi SS; Al-Tikriti MS; Baldwin RM; Seibyl JP; Innis RB
    J Nucl Med; 2000 Sep; 41(9):1552-60. PubMed ID: 10994738
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alterations in nicotinic α4β2 receptor binding in vascular dementia using ¹²³I-5IA-85380 SPECT: comparison with regional cerebral blood flow.
    Colloby SJ; Firbank MJ; Pakrasi S; Perry EK; Pimlott SL; Wyper DJ; McKeith IG; Williams ED; O'Brien JT
    Neurobiol Aging; 2011 Feb; 32(2):293-301. PubMed ID: 19269714
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Temporal change in human nicotinic acetylcholine receptor after smoking cessation: 5IA SPECT study.
    Mamede M; Ishizu K; Ueda M; Mukai T; Iida Y; Kawashima H; Fukuyama H; Togashi K; Saji H
    J Nucl Med; 2007 Nov; 48(11):1829-35. PubMed ID: 17942810
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alpha4beta2 nicotinic receptor status in Alzheimer's disease using 123I-5IA-85380 single-photon-emission computed tomography.
    O'Brien JT; Colloby SJ; Pakrasi S; Perry EK; Pimlott SL; Wyper DJ; McKeith IG; Williams ED
    J Neurol Neurosurg Psychiatry; 2007 Apr; 78(4):356-62. PubMed ID: 17135460
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.